Study Stopped
insufficent enrollment
Sickle Cell Trait and the Risk of Venous Thromboembolism
SCT&DVT
2 other identifiers
observational
34
1 country
1
Brief Summary
The purpose of this trial is to investigate D-Dimer levels, a surrogate marker of venous thromboembolism, in pregnant/postpartum white women as compared to pregnant/postpartum black women, and pregnant/postpartum women with sickle cell trait. The investigators will determine whether increased D-Dimer levels are reflected in a greater incidence of thrombosis in the postpartum patient, as well as the prevalence of symptomatic venous thrombosis in black patients as compared to pregnant white patients and women with sickle cell trait. The investigators will also investigate the effect of blood group on these parameters. If there is evidence that there is an increased risk of thrombosis in sickle cell trait, the investigators will plan a trial of prophylactic anticoagulation during the last trimester and the four weeks post partum for patients with sickle cell trait and compare this population to patients who do not receive prophylactic anticoagulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2010
CompletedFirst Posted
Study publicly available on registry
June 23, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedResults Posted
Study results publicly available
January 2, 2020
CompletedDecember 17, 2020
December 1, 2020
11 months
June 21, 2010
October 16, 2019
December 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
D-Dimer Levels Than in Black Women With Hb AA and White Women With Hb AA.
High D-Dimer levels are regarded as potentially prothrombotic markers and are often elevated in pregnancy and the postpartum. There are some data to suggest that sickle cell trait may also be prothrombotic.To investigate whether D-Dimer levels are higher in black peripartum women with SCT than in black or white pregnant/postpartum patients who have Hb AA, we will measure the D-Dimer, on a continuous scale, in the pregnant/postpartum population of each group. It is known that D-Dimer levels \>1.0 mg/ml may be predictive of increased thrombotic risk. We will compare mean D-Dimer of Black SCT women, Black AA women and White AA women to determine whether higher D-Dimer levels, which may be a measure of hypercoagulability, are higher in women with SCT.
Date of delivery until 4-5 weeks postpartum.
Study Arms (3)
White women with Hb AA
White pregnant and postpartum women with Hb AA
Black women with Hb AA
Black pregnant and postpartum women with HbAA
Black women with Sickle Trait
Black pregnant and postpartum women with HbAS
Eligibility Criteria
Pregnant and postpartum women
You may qualify if:
- Peripartum women (White, Black) with Hemoglobin AA or AS
You may not qualify if:
- Hispanic ethnicity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montefiore Medical Center (Einstein)
The Bronx, New York, 10461, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Henny Billett
- Organization
- Albert Einstein College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Henny H Billett, MD MSc
Albert Einstein College of Medicine/Montefiore Medical Ctr
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Clinical Medicine and Pathology
Study Record Dates
First Submitted
June 21, 2010
First Posted
June 23, 2010
Study Start
July 1, 2010
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
December 17, 2020
Results First Posted
January 2, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share
No plans at present